India's Pharmaceutical Exports

Country Profile

Qatar

Qatar is an emerging destination for Indian pharmaceutical exports — $13.6M in FY 2025–26, with 10.5× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $233K. The compound annual growth rate since FY2015 stands at 23.8%.

🇶🇦 $13.6M · 10.5× growth since FY2015 · 23.8% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$13.6M
Exports FY2025–26 DGCIS
10.5×
Growth FY2015→2026
23.8%
CAGR FY2015→2026
64%
Medicines Share
5
Product Categories Supplied
Qatar is an emerging destination for Indian pharmaceutical exports — $13.6M in FY 2025–26, with 10.5× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $233K. The compound annual growth rate since FY2015 stands at 23.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $8.70M (64.0%) Surgical & Hospital Supplies $2.23M (16.4%) Traditional & Herbal $2.03M (14.9%) Medicine Ingredients $393K (2.9%) Vaccines $233K (1.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Qatar in the RBI overseas direct investment dataset (2011–2026).